For the quarter ended December 2024, EverCommerce (EVCM) reported revenue of $175 million, up 3.3% over the same period last year. EPS came in at -$0.07, compared to -$0.12 in the year-ago quarter.

The reported revenue represents a surprise of +2.97% over the Zacks Consensus Estimate of $169.96 million. With the consensus EPS estimate being -$0.02, the EPS surprise was -250.00%.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how EverCommerce performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Revenues- Subscription and transaction fees: $139.01 million versus the four-analyst average estimate of $136.91 million. The reported number represents a year-over-year change of +4.2%.
• Revenues- Other: $6.38 million compared to the $4.73 million average estimate based on four analysts. The reported number represents a change of +8.2% year over year.
• Revenues- Marketing technology solutions: $29.61 million versus $28.26 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a -1.6% change.

View all Key Company Metrics for EverCommerce here>>>

Shares of EverCommerce have returned -16% over the past month versus the Zacks S&P 500 composite's -7.4% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

EverCommerce Inc. (EVCM) : Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research